Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,755 | 73 | 99.6% |
| Education | $16.24 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $783.11 | 21 | $0 (2023) |
| Stryker Corporation | $547.70 | 7 | $0 (2023) |
| ABBVIE INC. | $519.86 | 10 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $472.51 | 6 | $0 (2023) |
| Smith+Nephew, Inc. | $369.93 | 5 | $0 (2022) |
| Cardiovascular Systems Inc. | $168.84 | 1 | $0 (2023) |
| Amgen Inc. | $161.95 | 2 | $0 (2024) |
| Trilliant Surgical LLC. | $150.92 | 2 | $0 (2018) |
| Integra LifeSciences Corporation | $120.29 | 2 | $0 (2022) |
| Pacira Pharmaceuticals Incorporated | $118.46 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $547.40 | 12 | ABBVIE INC. ($281.39) |
| 2023 | $992.24 | 9 | Horizon Therapeutics plc ($464.86) |
| 2022 | $1,105 | 13 | Stryker Corporation ($277.93) |
| 2021 | $317.26 | 9 | Paratek Pharmaceuticals, Inc. ($146.91) |
| 2020 | $90.38 | 4 | Horizon Therapeutics plc ($34.26) |
| 2019 | $381.88 | 18 | Smith+Nephew, Inc. ($207.25) |
| 2018 | $92.55 | 3 | Trilliant Surgical LLC. ($58.08) |
| 2017 | $244.26 | 6 | AbbVie, Inc. ($101.76) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $132.62 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/04/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/13/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $39.75 | General |
| 09/04/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/04/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/02/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/15/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 05/03/2024 | Fortis Surgical, LLC | — | Food and Beverage | In-kind items and services | $21.93 | General |
| 03/02/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/01/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/24/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $120.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/17/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/29/2023 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 08/10/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $113.50 | General |
| Category: KRYSTEXXA | ||||||
| 07/13/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $118.45 | General |
| Category: KRYSTEXXA | ||||||
| 05/24/2023 | Stryker Corporation | ORTHOLOC 3DI CROSSCHECK (Device) | Food and Beverage | In-kind items and services | $144.28 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 05/10/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $113.62 | General |
| Category: KRYSTEXXA | ||||||
| 03/21/2023 | Cardiovascular Systems Inc. | Diamondback Peripheral (Device) | Food and Beverage | Cash or cash equivalent | $168.84 | General |
| Category: Atherectomy Device | ||||||
| 03/21/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $119.29 | General |
| Category: KRYSTEXXA | ||||||
| 03/14/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $85.49 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/21/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $108.84 | General |
| Category: ANTIBIOTIC | ||||||
| 11/15/2022 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $118.46 | General |
| Category: Pain Management | ||||||
| 10/25/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTIBIOTIC | ||||||
| 10/18/2022 | Stryker Corporation | VALOR (Device), ANCHORAGE, ORTHOLOC 3DI | Food and Beverage | In-kind items and services | $95.14 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 10/18/2022 | Stryker Corporation | VALOR (Device) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,729 | 3,446 | $309,098 | $181,129 |
| 2022 | 31 | 2,946 | 12,556 | $997,032 | $706,204 |
| 2021 | 21 | 2,156 | 5,208 | $337,329 | $235,332 |
| 2020 | 16 | 2,090 | 4,747 | $306,956 | $211,352 |
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 220 | 580 | $65,984 | $38,408 | 58.2% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 67 | 765 | $33,553 | $26,308 | 78.4% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 183 | 285 | $29,766 | $14,391 | 48.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 120 | 120 | $25,119 | $13,087 | 52.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 126 | $20,168 | $12,370 | 61.3% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 222 | 347 | $19,106 | $11,452 | 59.9% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 77 | 120 | $18,958 | $9,345 | 49.3% |
| 11730 | Simple separation of fingernail or toenail from nail bed, first nail | Office | 2023 | 101 | 114 | $16,813 | $8,646 | 51.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 101 | 102 | $14,405 | $6,821 | 47.3% |
| 11307 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 37 | 64 | $11,369 | $5,925 | 52.1% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 65 | 160 | $7,018 | $5,502 | 78.4% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 124 | 207 | $9,156 | $5,312 | 58.0% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 22 | 46 | $7,612 | $4,456 | 58.5% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 49 | 95 | $4,167 | $3,267 | 78.4% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 49 | 94 | $4,123 | $3,233 | 78.4% |
| 11765 | Removal of skin of fingernail or toenail | Office | 2023 | 19 | 20 | $4,134 | $2,537 | 61.4% |
| 11750 | Permanent removal fingernail or toenail | Office | 2023 | 19 | 19 | $3,890 | $2,382 | 61.2% |
| 17250 | Application of chemical to stop tissue regrowth in wound | Office | 2023 | 25 | 26 | $2,992 | $1,517 | 50.7% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2023 | 27 | 44 | $1,930 | $1,513 | 78.4% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 27 | 31 | $2,293 | $1,372 | 59.8% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 12 | $1,870 | $1,087 | 58.1% |
| 20604 | Aspiration and/or injection of fluid from small joint using ultrasound guidance | Office | 2023 | 16 | 21 | $2,192 | $962.12 | 43.9% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 19 | 22 | $1,604 | $899.04 | 56.0% |
| 29540 | Placement of strapping to ankle or foot | Office | 2023 | 12 | 12 | $457.31 | $209.26 | 45.8% |
| 29550 | Placement of strapping to toes | Office | 2023 | 14 | 14 | $421.12 | $127.30 | 30.2% |
About Dr. William Eng, DPM
Dr. William Eng, DPM is a Podiatrist healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013944909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Eng, DPM has received a total of $3,771 in payments from pharmaceutical and medical device companies, with $547.40 received in 2024. These payments were reported across 74 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,755).
As a Medicare-enrolled provider, Eng has provided services to 8,921 Medicare beneficiaries, totaling 25,957 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Practice Information
- Specialty Podiatrist
- Location Richmond, VA
- Active Since 06/27/2006
- Last Updated 06/30/2010
- Taxonomy Code 213E00000X
- Entity Type Individual
- NPI Number 1013944909
Products in Payments
- KRYSTEXXA (Biological) $819.36
- NUZYRA (Drug) $472.51
- DALVANCE (Drug) $305.20
- HOFFMANN (Device) $247.10
- Santyl (Drug) $236.19
- Diamondback Peripheral (Device) $168.84
- ORTHOLOC 3DI CROSSCHECK (Device) $144.28
- TENOGLIDE (Device) $120.29
- Exparel (Drug) $118.46
- VALOR (Device) $114.14
- TEFLARO (Drug) $112.90
- QUTENZA (Drug) $104.00
- PICO (Device) $103.01
- Biologics (Device) $92.84
- RAYOS (Drug) $91.94
- VIMOVO (Drug) $59.30
- Tiger Cannulated Screws (Device) $58.08
- INNOVAMATRIX AC (Device) $43.80
- RENASYS GO v2 HOME (Device) $30.73
- EASY CLIP (Device) $27.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Podiatrist Doctors in Richmond
Cassey Crowell, Dpm, DPM
Podiatrist — Payments: $8,379
Rachel Hensley, Dpm, DPM
Podiatrist — Payments: $6,419
Tiffanie Liu
Podiatrist — Payments: $4,228
Scott Vantre, Dpm, DPM
Podiatrist — Payments: $3,243
Glen Wilensky, Dpm, DPM
Podiatrist — Payments: $2,900
Dr. Sonya Faircloth, D.p.m, D.P.M
Podiatrist — Payments: $2,213